These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34877075)

  • 61. Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and Perspectives.
    Alberti A; Bossi P
    Front Oncol; 2021; 11():727027. PubMed ID: 35070956
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pembrolizumab and concurrent hypo-fractionated radiotherapy for advanced non-resectable cutaneous squamous cell carcinoma.
    Lavaud J; Blom A; Longvert C; Fort M; Funck-Brentano E; Saiag P
    Eur J Dermatol; 2019 Dec; 29(6):636-640. PubMed ID: 31903954
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement.
    Massey PR; Schmults CD; Li SJ; Arron ST; Asgari MM; Bouwes Bavinck JN; Billingsley E; Blalock TW; Blasdale K; Carroll BT; Carucci JA; Chong AH; Christensen SR; Chung CL; DeSimone JA; Ducroux E; Escutia-Muñoz B; Ferrándiz-Pulido C; Fox MC; Genders RE; Geusau A; Gjersvik P; Hanlon AM; Olasz Harken EB; Hofbauer GFL; Hopkins RS; Leitenberger JJ; Loss MJ; Del Marmol V; Mascaró JM; Myers SA; Nguyen BT; Oliveira WRP; Otley CC; Proby CM; Rácz E; Ruiz-Salas V; Samie FH; Seçkin D; Shah SN; Shin TM; Shumack SP; Soon SL; Stasko T; Zavattaro E; Zeitouni NC; Zwald FO; Harwood CA; Jambusaria-Pahlajani A
    JAMA Dermatol; 2021 Oct; 157(10):1219-1226. PubMed ID: 34468690
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Consensus for Nonmelanoma Skin Cancer Treatment, Part II: Squamous Cell Carcinoma, Including a Cost Analysis of Treatment Methods.
    Kauvar AN; Arpey CJ; Hruza G; Olbricht SM; Bennett R; Mahmoud BH
    Dermatol Surg; 2015 Nov; 41(11):1214-40. PubMed ID: 26445288
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Risk Factors and Prognosis for Metastatic Cutaneous Squamous Cell Carcinoma: A Cohort Study.
    Knuutila JS; Riihilä P; Kurki S; Nissinen L; Kähäri VM
    Acta Derm Venereol; 2020 Sep; 100(16):adv00266. PubMed ID: 32930344
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone.
    Marrazzo G; Zitelli JA; Brodland D
    J Am Acad Dermatol; 2019 Mar; 80(3):633-638. PubMed ID: 30244064
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mohs surgery in metastatic cancer: renal cell carcinoma solitary cutaneous metastasis and visceral tumor metastases to skin treated with microscopically controlled surgical excision.
    Anzalone CL; Cohen PR; Migden MR; Tannir NM
    Int J Dermatol; 2013 Jul; 52(7):856-61. PubMed ID: 23675612
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Electrochemotherapy for the treatment of cutaneous squamous cell carcinoma: The INSPECT experience (2008-2020).
    Bertino G; Groselj A; Campana LG; Kunte C; Schepler H; Gehl J; Muir T; Clover JAP; Quaglino P; Kis E; Mascherini M; Bisase B; Pecorari G; Bechara F; Matteucci P; Odili J; Russano F; Orlando A; Pritchard-Jones R; Moir G; Mowatt D; Silvestri B; Seccia V; Saxinger W; de Terlizzi F; Sersa G
    Front Oncol; 2022; 12():951662. PubMed ID: 36203425
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Value of Adjuvant Radiotherapy in Cutaneous Squamous Cell Carcinoma: A Review.
    Cañueto J; Jaka A; Toll A
    Actas Dermosifiliogr (Engl Ed); 2018; 109(6):476-484. PubMed ID: 29759308
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Biomarker and Pathologic Predictors of Cutaneous Squamous Cell Carcinoma Aggressiveness.
    Khandelwal AR; Ma X; Egan P; Kaskas NM; Moore-Medlin T; Caldito G; Abreo F; Gu X; Aubrey L; Milligan E; Nathan CA
    Otolaryngol Head Neck Surg; 2016 Aug; 155(2):281-8. PubMed ID: 27095050
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cutaneous Squamous Cell Carcinoma: From Biology to Therapy.
    Corchado-Cobos R; García-Sancha N; González-Sarmiento R; Pérez-Losada J; Cañueto J
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331425
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Systematic review of the prevalence of nodal metastases and the prognostic utility of sentinel lymph node biopsy in cutaneous squamous cell carcinoma.
    Tejera-Vaquerizo A; García-Doval I; Llombart B; Cañueto J; Martorell-Calatayud A; Descalzo-Gallego MA; Sanmartín O
    J Dermatol; 2018 Jul; 45(7):781-790. PubMed ID: 29701281
    [TBL] [Abstract][Full Text] [Related]  

  • 73. PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California.
    In GK; Vaidya P; Filkins A; Hermel DJ; King KG; Ragab O; Tseng WW; Swanson M; Kokot N; Lang JE; Menendez L; DeClerck B; Kim G; Hu JC; Terando A; Jadvar H; Ricker C; Miller KA; Peng DH; Wysong A
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1803-1811. PubMed ID: 33210210
    [TBL] [Abstract][Full Text] [Related]  

  • 74. From Morphea to Dermatofibrosarcoma Protuberans.
    Crnarić I; Šitum M; Delaš Aždajić M; Vučić M; Buljan M
    Acta Dermatovenerol Croat; 2022 Sep; 30(2):113-115. PubMed ID: 36254545
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Treatment of locally advanced and metastatic cutaneous squamous cell carcinoma.].
    Greco S; Pugliese G; Rimini M; Depenni R
    Recenti Prog Med; 2021 Jun; 112(6):69e-74e. PubMed ID: 34128944
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629.
    Hughes BGM; Mendoza RG; Basset-Seguin N; Vornicova O; Schachter J; Joshi A; Meyer N; Grange F; Piulats JM; Bauman JR; Chirovsky D; Zhang P; Gumuscu B; Swaby RF; Grob JJ
    Dermatol Ther (Heidelb); 2021 Oct; 11(5):1777-1790. PubMed ID: 34558040
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of Gene Expression Profile Testing on the Management of Squamous Cell Carcinoma by Dermatologists.
    Rebeca T; Giselle P; Litchman GH; Rigel DS
    J Drugs Dermatol; 2019 Oct; 18(10):980-984. PubMed ID: 31584775
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Overview of guideline recommendations for the management of high-risk and advanced cutaneous squamous cell carcinoma.
    Dessinioti C; Stratigos AJ
    J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():11-18. PubMed ID: 34855249
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High-risk cutaneous squamous cell carcinoma.
    Nuño-González A; Vicente-Martín FJ; Pinedo-Moraleda F; López-Estebaranz JL
    Actas Dermosifiliogr; 2012 Sep; 103(7):567-78. PubMed ID: 22261673
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of the utility of localized adjuvant radiation for node-negative primary cutaneous squamous cell carcinoma with clear histologic margins.
    Ruiz ES; Koyfman SA; Que SKT; Kass J; Schmults CD
    J Am Acad Dermatol; 2020 Feb; 82(2):420-429. PubMed ID: 31349042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.